Synergy Pharmaceuticals Inc., of New York, said it priced a private offering of $175 million aggregate principal amount of 7.50 percent convertible senior notes due in 2019. The company also granted the initial purchasers of the notes an option to purchase up to an additional $25 million of the notes.